This is because they are more prone to degradation and oxidation
Risk allele carriers might not only benefit from the latest generations of GLP1R agonists including dual GLP1R/GIPR agonists, but also from recently developed GLP1R PAMs or Gs/cAMP pathway-biased ligands
"Until more data on solid diets is available, a conservative approach with a liquid diet while continuing therapy is advisable." The findings were reported in the paper, Quantified Metrics of Gastric Emptying Delay by Glucagon-Like Peptide-1 Agonists: A Systematic Review and Meta-Analysis With Insights for Periprocedural Management, published in The American Journal of Gastroenterology
If taking ozempic makes you less hungry and you eat less food, which is what 100% of the people take it say, how they lose weight is that they eat less, right
According to CBS News, a GLP-1 lawsuit was filed by a woman who began Ozempic injections in 2022 and later developed severe stomach paralysis